pemgarda emergency use authorization

FDA Shoots Down Invivyd’s Bid to Expand EUA for COVID-19 Antibody

Pemgarda has a standing emergency use authorization as a prophylaxis for immunocompromised patients, but FDA’s stringent requirements for antibody activity boxed out its potential use as a post-exposure treatment.

Business Insider · 1d

Invivyd says FDA declines request to expand existing EUA of PEMGARDA

Invivyd (IVVD) announced that Invivyd’s request to expand the existing emergency use authorization for pre-exposure prophylaxis of COVID-19 EUA

Seeking Alpha on MSN · 1d

Invivyd shares drop as FDA declines company's COVID-19 treatment EUA expansion

Monday said that its request to expand the existing emergency use authorization of PEMGARDA (pemivibart) to include treatment of mild-to-moderate COVID-19 for immunocompromised persons who have no alternative therapeutic options,

MarketWatch · 1d

Invivyd Shares Down as Regulators Decline Expanded Use for Covid-19 Treatment

The commercial-stage biopharmaceutical company said its request to expand the existing emergency use authorization of the drug, also called pemivibart, to treat mild-to-moderate Covid-19 in more people was declined by the Food and Drug Administration.

FDA Rejects Invivyd's Request To Expand Emergency Authorization For Preventive COVID-19 Antibody For Immunocompromised Patients

Invivyd's bid to expand Pemgarda's EUA for COVID-19 treatment was denied by the FDA. The company will share new data on ...

Invivyd news ‘disappointing’ but not in model, says H.C. Wainwright

H.C. Wainwright maintains a Buy rating on Invivyd (IVVD) with a $10 price target after the FDA rejected its submission to expand Pemgarda’s ...

pharmaphorum5d

AstraZeneca files rival to Pemgarda for COVID PrEP

There is currently one antibody available for PrEP in COVID-19 – Invivyd’s Pemgarda (pemivibart) – which was granted Emergency Use Authorization (EUA) in the US in March for adults and ...

Seeking Alpha21d

I See The Bull Case For Invivyd, But I'm Not Married To It

On top of that, PEMGARDA’s Emergency Use Authorization (EUA) status makes things a bit precarious. Its sales depend entirely on viral variants staying susceptible and regulators continuing to ...

Nasdaq29d

Invivyd Submits Updated Immunobridging Data To FDA For PEMGARDA EUA Amendment

on Monday announced the submission of an updated immunobridging analysis to the U.S. Food and Drug Administration or FDA in support of its Emergency Use Authorization or EUA amendment request ...

Healthline12d

Pemgarda Side Effects and Tips for Managing Them

Pemgarda (pemivibart) can cause side effects that range from mild to serious. More common side effects include fatigue and infusion-related reactions. If side effects become difficult to tolerate ...

Stockhouse1mon

Invivyd Announces Continued Neutralizing Activity of PEMGARDA(TM) (pemivibart) Against Dominant SARS-CoV-2 Variant XEC

The emergency use of PEMGARDA is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological ...

Nasdaq22d

Invivyd Announces Preliminary Fourth Quarter 2024 Financial Results, Strong Revenue Growth, and Reiterates Goal of Near-Term Profitability

Results that may be inaccessible to you are currently showing.

Hide inaccessible results